2021 Liver Fibrosis SIG: Multidisciplinary Perspectives in Developing New Treatments for NASH Fibrosis
Recorded On: 11/11/2021
Already registered?
Sign in now.
This SIG program shares exciting new discoveries in liver fibrosis related to NASH, such as molecular mechanisms and translational aspects of fibrosis and cirrhosis, and translation of findings into humans. Experts share significant new information on the potential role of hepatocytes and crosstalk with non-parenchymal cells in NASH-fibrosis, with emphasis on molecular mechanisms, and potential non-invasive biomarkers and treatments.
Complete
Next
Failed
Available
Locked